Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 4/20 | 0.52 |
| ▸ | MMP9 | P14780 | 4/20 | 0.52 |
| ▸ | MMP12 | P39900 | 4/20 | 0.52 |
| ▸ | MMP14 | P50281 | 1/20 | 0.52 |
| ▸ | MMP15 | P51511 | 1/20 | 0.52 |
| ▸ | MMP16 | P51512 | 1/20 | 0.52 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.52 |
| ▸ | FFAR1 | O14842 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | VCP | P55072 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ACACB | O00763 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1744392 | 0.99 | MMP2 (0.51) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1746516 | 0.93 | MMP2 (0.50) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1746510 | 0.93 | MMP2 (0.50) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1746507 | 0.93 | MMP2 (0.50) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1070286 | 0.86 | MEN1 (0.53) | GAAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1745367 | 0.85 | GAA (0.39) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1745364 | 0.85 | GAA (0.39) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL1745365 | 0.85 | GAA (0.39) | MMP2MMP9MMP12MMP14MMP15 | |
| SCHEMBL8999201 | 0.83 | NPC1 (0.50) | GAAMAPTNPC1HTTRAB9A | |
| SCHEMBL8999208 | 0.83 | NPC1 (0.50) | GAAMAPTNPC1HTTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110039841-A1 | Novel compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2011-02-17 | — | — | US | disclosed |
| EP-1763511-B1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | HIGH POINT PHARMACEUTICALS LLC (US) | 2010-07-28 | — | — | EP | disclosed |
| EP-1763511-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2007-03-21 | — | — | EP | disclosed |
| WO-2005105735-A1 | PHENOXYACETIC ACID DERIVATIVES AS PPAR AGONISTS | NOVO NORDISK A/S (DK) | 2005-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110039841-A1 | Novel compounds, their preparation and use | PPARG, PPARD, PPARA | MMP2 3343/4885MMP9 4089/4885MMP12 2994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.